Upregulation of Trop-2 quantitatively stimulates human cancer growth
2012 · Oncogene · 311 citations
https://doi.org/10.1038/onc.2012.36
R
Rossano Lattanzio
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
218
Papers
3.8K
Citations
35
h-index
73
i10-index
Rossano Lattanzio is an academic researcher from University of Chieti-Pescara. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cell Adhesion Molecules Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 35, co-authored 186 publications.
ORCID: 0000-0001-9803-4476Papers by this author
worksTrop-2 Is a Determinant of Breast Cancer Survival
2014 · PLoS ONE · 209 citations
https://doi.org/10.1371/journal.pone.0096993
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
2013 · Cell Death and Disease · 84 citations
https://doi.org/10.1038/cddis.2013.139
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
2015 · Cell Death and Disease · 83 citations
https://doi.org/10.1038/cddis.2015.192
Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis
2021 · Neoplasia · 63 citations
https://doi.org/10.1016/j.neo.2021.03.006
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
2019 · BMC Cancer · 56 citations
https://doi.org/10.1186/s12885-019-5616-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat